IVVD
Invivyd, Inc.
Key Financials
Operating Income
$-55560000
↑ 68.6%
Revenue
$53.4M
↑ 110.5%
Net Income
$-52489000
↑ 69.1%
EPS (Diluted)
$-0.30
↑ 79.0%
Cash & Equivalents
$226.7M
↑ 226.9%
Total Liabilities
$35.3M
↓ 43.0%
Total Assets
$276.9M
↑ 113.8%
Shareholders' Equity
$241.5M
↑ 257.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
| 3 | 8/4/2026 | View on SEC |
| SCHEDULE 13G | 7/28/2026 | View on SEC |
| 8-K | 7/24/2026 | View on SEC |
| 8-K | 7/6/2026 | View on SEC |
| 4 | 5/21/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IVVD |
| Company Name | Invivyd, Inc. |
| CIK | 1832038 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (781) 819-0080 |